Kentucky 2024 Regular Session

Kentucky House Bill HB768

Introduced
2/26/24  

Caption

AN ACT relating to coverage for cranial conditions.

Impact

The implementation of HB 768 could significantly alter the landscape of health insurance provisions in Kentucky, particularly for pediatric healthcare. By ensuring coverage for treatments that are generally deemed cosmetic, the bill prioritizes medical necessity over insurance classifications that might restrict access. This law would potentially increase financial responsibilities for health plans but may lead to improved health outcomes for children suffering from these conditions, demonstrating a proactive approach in pediatric healthcare legislation.

Summary

House Bill 768 aims to mandate health benefit plans to provide coverage for the treatment of cranial conditions, specifically plagiocephaly and cranial banding. The bill targets insurance policies under Kentucky law, ensuring that such treatments are not labeled as cosmetic to qualify for coverage. It establishes clear conditions under which health benefit plans must operate, aiming to improve access to necessary medical treatments for children with cranial conditions, enhancing regional healthcare standards and patient rights.

Sentiment

General sentiment regarding HB 768 appears to be positive, particularly among healthcare advocates and parents of affected children. Supporters argue that it is crucial to remove barriers that prevent access to necessary treatments. However, there might be some contention among insurers concerned about increased costs associated with expanded coverage. The debate reflects broader issues surrounding health insurance regulations and the challenges of balancing comprehensive coverage with financial sustainability for providers.

Contention

Potential points of contention arise primarily regarding the definition of medical necessity versus cosmetic treatment. Insurers may be apprehensive about how the bill will influence their underwriting practices and the claims process. Additionally, there may be discussions on the effects of these requirements on insurance premiums as providers adjust to a new mandate that expands coverage. The ramifications of such a law could lead to varying interpretations of healthcare costs and services across the state.

Companion Bills

No companion bills found.

Previously Filed As

KY HB589

AN ACT relating to coverage for cranial conditions.

KY HB528

AN ACT relating to coverage for substance use disorder.

KY HB68

AN ACT relating to coverage for injectable epinephrine devices.

KY HB278

AN ACT relating to contraceptive coverage.

KY HB299

AN ACT relating to coverage for hepatitis C virus infection.

KY HB408

AN ACT relating to coverage for the care of children.

KY HB283

AN ACT relating to coverage for the treatment of postpartum mood disorders.

KY HB208

AN ACT relating to coverage of mental health wellness examinations.

KY HB284

AN ACT relating to mental health coverage in connection with pregnancy.

KY HB495

AN ACT relating to coverage for cancer detection.

Similar Bills

KY HB412

AN ACT relating to coverage for the treatment of postpartum mood disorders.

KY HB68

AN ACT relating to coverage for injectable epinephrine devices.

KY HB183

AN ACT relating to coverage for injectable epinephrine devices.

KY HB98

AN ACT relating to coverage for hepatitis C virus infection testing and treatment in pregnant women.

KY HB709

AN ACT relating to mental health coverage in connection with pregnancy.

KY HB55

AN ACT relating to coverage of mental health wellness examinations.

KY HB556

AN ACT relating to coverage for injectable epinephrine devices.

KY HB322

AN ACT relating to coverage for hepatitis C virus infection.